创美药业股份有限公司（港交所股票代码：02289）于2026年8月3日公布了截至2026年7月31日止的股份变动月报表。公告显示，截至报告期末，公司普通股H股注册股本为1.08亿元人民币（面值每股1元），合计已发行股本108,000,000股，与上月期末保持一致。
报告期内，公司无新增发行、购回或库藏股活动，未出现股份期权、权证或可换股票据等权益工具的授出或变动。公司同时确认符合主板上市规则对于公众持股量的相关要求。截至2026年7月31日，公司股本结构整体保持稳定。
本次公告由公司秘书姚洁晞签署，创美药业表示将严格遵守香港联交所《上市规则》及相关法律法规，持续披露公司股份变动及股本情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.